BriaCell Therapeutics BCTX
NASDAQ BCTX
$4.04 -0.07 (-1.70%)
At close: Oct 2, 2026 · 4:00 PM EDT

BriaCell Therapeutics (BCTX) Return on Capital Employed [ROCE] (2022 - 2026)

Updated

BriaCell Therapeutics (BCTX) recorded Return on Capital Employed [ROCE] of -119.77% in fiscal Q3 2026 (quarter ended Apr 30, 2026), up 156.08 percentage points from -275.85% a year earlier and up 32.78 percentage points from the prior quarter.

Analysis

BriaCell Therapeutics (BCTX) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends

For FY2025 (ended Jul 31, 2025), BriaCell Therapeutics reported Return on Capital Employed [ROCE] of -278.08%, up 89.93 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a four-year change of -253.80 percentage points (FY2021 to FY2025).
  • Across earlier fiscal years, Return on Capital Employed [ROCE] came in at -368.01% in FY2024 (-297.64 pp), -70.38% in FY2023 (-39.41 pp), -30.97% in FY2022 (-6.68 pp) and -24.28% in FY2021.
  • The fiscal Q3 2026 figure is the highest quarterly Return on Capital Employed [ROCE] since fiscal Q4 2023.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased for three consecutive quarters, with an average year-over-year change of +223.65 percentage points over the last six quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 1158.15 percentage points in fiscal Q3 2025, against a drop of 1365.94 percentage points in fiscal Q3 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -152.55% (Q2 2026), -216.27% (Q1 2026) and -177.26% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 BriaCell Therapeutics 29.29 Mn 28.64 Mn - -119.77%
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -119.77%
Jan 31, 2026 -152.55%
Oct 31, 2025 -216.27%
Jul 31, 2025 -177.26%
Apr 30, 2025 -275.85%
Jan 31, 2025 -586.50%
Oct 31, 2024 -950.34%
Apr 30, 2024 -1,434.00%
Jan 31, 2024 -275.77%
Oct 31, 2023 -120.72%
Jul 31, 2023 -87.35%
Apr 30, 2023 -68.07%
Jan 31, 2023 -54.01%
Oct 31, 2022 -46.55%
Jul 31, 2022 -35.08%
Apr 30, 2022 -24.72%
API Access

BriaCell Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BCTX&period=max&api_key=YOUR_API_KEY